natgillin/translations-raw huggingface dataset:
S ådan skal De tage Keppra
How to take Keppra
S ærlige advarsler og forsigtighedsregler vedrørende brugen
Special warnings and precautions for use
S  1 mg/l og R > 1 mg/l
S  1 mg/l and R > 1 mg/l
S  1 mg/l og R > 4 mg/l
S  1 mg/l and R > 4 mg/l
S(+) metadon
S(+) methadone
S(+) metadon: AUC: ↓ 16 %
S(+) methadone: AUC: ↓ 16
S, Det anbefales at blodtrykket periodisk p-å patienter over 65 år.
It is recommended that blood pressure is measured periodically in patients over 65 years.
S- og R- warfarin.
List of excipients
S-169 70 Solna
169 70 Solna
S-Ibuprofen AUC0-∞ ↑ 100 %
S-Ibuprofen AUC0-∞ ↑ 100
S-ibuprofen AUC0-∞ ↑ 100%
S-Ibuprofen AUC0-∞  100
S-Ibuprofen Cmax ↑ 20 %
S-Ibuprofen Cmax ↑ 20
S-kreatinin
Creatinine value
S-metadon AUC ↓ 63%
(thrombogenic effect) or increase
S-methadon
S-methadone
S-methadon AUCτ ↑ 103%
S-methadone AUCτ  103
S-methadon Cmaks. ↓ 17 %
S-methadone Cmax ↓ 17
S-PSUR fremsendelse til Rapporteur og CHMP-medlemmer på dag 45.
S-PSUR submission to the Rapporteur and CHMP members on Day 45.
S-PSUR indsendes til Rapporteur og CHMP medlemmer på dag 45.
S-PSUR submission to the Rapporteur and CHMP members on Day 45.
S-PSUR indsendes til Rapporteur og CHMP-medlemmer på dag 45.
S-PSUR submission to the Rapporteur and CHMP members on Day 45.
S-warfarin Cmax ↔
Pantoprazole
S-warfarin Cmin ikke undersøgt
Not studied.
S-warfarins farmakokinetik blev vurderet efter en enkeltdosis warfarin på 25 mg givet alene eller administreret samtidigt med eller 24 eller 72 timer efter indgift af en enkeltdosis oritavancin på 1.200 mg.
S-warfarin pharmacokinetics were evaluated following a single dose of warfarin 25mg given alone, or administered at the start, 24, or 72 hours after a single 1200mg dose of oritavancin.
S. aureus (alle)
S. aureus (all)
S. aureus) viste naturlig in vitro resistens over for cefovecin
S. aureus) exhibited natural in vitro resistance to cefovecin
S. pneumoniae S  1 mg/l og R > 1 mg/l
S. pneumoniae S  1 mg/l and R > 1 mg/l
S. pneumoniae, men niveauet var lavere end i tre-dosis programmet.
S. pneumoniae, but to a lower level than the three-dose schedule.
S. xylosus, S. schleiferi, S. epidermidis) er 9,5 %.
S. xylosus, S. schleiferi, S. epidermidis) is 9.5 %.
S.A. Alcon - Couvreur N.V
S.A. Alcon-Couvreur N.V
S.A. Alcon - Couvreur N.V Rijksweg 14
S.A. Alcon – Couvreur N.V Rijksweg 14
S.A. Alcon-Couvreur N.V Rijksweg 14
S.A. Alcon–Couvreur N.V Rijksweg 14
S.A. Alcon-Couvreur N.V.,
S.A. Alcon - Couvreur N.V.,
S.A. Alson-Couvreur N.V., Rijksweg 14,
S.A. Alcon-Couvreur N.V., Rijksweg 14,
s.c.
SC use
S.C. Alcon Romania S.R.L.
Alcon Portugal – Produtos e Equipamentos Oftalmológicos, Lda.
S.C. Alcon Romania S.R.L.
S.C. Alcon Romania S.R.L
S.c. anvendelse
SC use
S.C. injektion.
S.C. injection
s.c. og i.v. anvendelse.
For subcutaneous and intravenous use.
S.C. Sindan-Pharma S.R.L. 11 Ion Michalache Blvd Bukarest
S.C. Sindan-Pharma S.R.L. 11 Ion Mihalache Blvd Bucharest
S.C. SindanPharma S.R.L. 11 Ion Mihalache Blvd Bukarest
S.C. Sindan-Pharma S.R.L. 11 Ion Mihalache Blvd Bucharest
s.c.eller i.v.
SC or IV injection.
S.S.156 km 47,600
S.S. 156 Km 47,600
S102X
R100T
S148N
G147E
S148R
S148N
S304N
I303N
S345P
P343L
SA Alcon-Courvreur NV Rijksweg 14
08320 El Masnou,
Sabe rvel inde holder lactose .
Sabe rvel contains lactose.
Sabervel 150 mg filmovertrukne tabletter
Sabervel 150 mg film-coated tablets
Sabervel 150 mg filmovertrukne tabletter er hvide, konkave, runde, filmovertrukne tabletter med 9 mm diameter
Sabervel 150 mg film-coated tablets are white, concave, round, film-coated tablets with 9 mm diameter.
Sabervel 150 mg filmovertrukne tabletter irbesartan
Sabervel 150 mg film-coated tablets irbesartan
Sabervel 300 mg filmovertrukne tabletter
Sabervel 300 mg film-coated tablets
Sabervel 300 mg filmovertrukne tabletter er hvide, konkave, runde, filmovertrukne tabletter med 11 mm diameter
Sabervel 300 mg film-coated tablets are white, concave, round, film-coated tablets with 11 mm diameter.
Sabervel 300 mg filmovertrukne tabletter irbesartan
Sabervel 300 mg film-coated tablets irbesartan
Sabervel 75 mg filmovertrukne tabletter
Sabervel 75 mg film-coated tablets
Sabervel 75 mg filmovertrukne tabletter er hvide, konkave, runde, filmovertrukne tabletter med 7 mm diameter
Sabervel 75 mg film-coated tablets are white, concave, round, film-coated tablets with 7 mm diameter.
Sabervel 75 mg filmovertrukne tabletter irbesartan
Sabervel 75 mg film-coated tablets irbesartan
Sabervel anvendes til voksne med essentiel hypertension (forhøjet blodtryk). ”Essentiel” betyder, at hypertensionen ikke har nogen umiddelbar årsag.
Sabervel is used in adults who have essential hypertension (high blood pressure). ‘Essential’ means that the hypertension has no obvious cause.
Sabervel er et ‘generisk lægemiddel’.
Sabervel is a ‘generic medicine’.
Sabervel kan tages med og uden mad.
Sabervel can be taken with or without food.
Sabervel skal tages ge nne m munde n.
Sabervel is for oral use .
Saccharinnatrium Natriumcarboxymethylcellulose Silica, kolloid
Sodium Carboxyl Methyl Cellulose Colloidal Silicon Dioxide
Saccharomyces cerevisiae ved rekombinant DNA-teknologi.
Saccharomyces cerevisiae by recombinant DNA technology.
Saccharose Histidin
Sucrose Histidine
Saccharose Mannitol (E421) Glycin
Sucrose Mannitol (E421) Glycine
Saccharose Mannitol Ravsyre
Sucrose Mannitol Succinic acid
Saccharose Natriumcitrat
Sucrose Sodium citrate
Saccharose og konserveringsmidler (E218 og E216)
Sucrose and preservatives (E218 and E216)
Saccharose Poloxamer 188
Sucrose Poloxamer 188
Saccharose Polysorbat 20 Methionin
Sucrose Polysorbate 20 Methionine
Saccharose Polysorbat 80
di potassium-hydrogen phosphate phosphoric acid sucrose Polysorbate 80
Saccharose Polysorbat 80
Sucrose Polysorbate 80
Saccharose Renset vand
Sucrose Purified water
Saccharose Sorbitol
Sucrose Sorbitol Dextran 40
Saccharose Sorbitol Dextran 40
Sucrose Sorbitol Dextran 40
Saccharose Trometamol
Sucrose Trometamol
Saccharose, glycin, L-histidin, natriumchlorid, polysorbat 80
Sucrose, glycine, L-histidine, sodium chloride, polysorbate 80.
Saccharose, histidin, glycin, natriumchlorid, kalciumchlorid, polysorbat 80.
Sucrose, histidine, glycine, sodium chloride, calcium chloride, polysorbate 80.
Saccharose, hydrolyseret gelatin, urea, natriumchlorid, kaliumdihydrogenphosphat, kaliumchlorid, mononatrium-L-glutamatmonohydrat, dinatriumphosphat, natriumhydroxid.
Sucrose, hydrolysed gelatin, urea, sodium chloride, potassium dihydrogen phosphate, potassium chloride, monosodium L-glutamate monohydrate, disodium phosphate, sodium hydroxide.
Saccharose, hydrolyseret gelatine, urinstof, natriumchlorid, sorbitol, mononatriumglutamat, natriumphosphat, natriumbicarbonat, kaliumphosphat, kaliumchlorid, medium 199 med Hanks salte, MEM, neomycin, phenolrødt, HCl, NaOH
Sucrose, hydrolysed gelatin, urea, sodium chloride, sorbitol, monosodium glutamate, sodium phosphate, sodium bicarbonate, potassium phosphate, potassium chloride, medium 199 with Hanks’ Salts, MEM, neomycin, phenol red, HCl, NaOH.
Saccharose, hydrolyseret gelatine, urinstof, natriumchlorid, sorbitol, mononatriumglutamat, natriumphosphat, natriumbicarbonat, kaliumphosphat, kaliumchlorid, medium 199 med Hanks salte, MEM, neomycin, phenolrødt, HCl, NaOH.
Sucrose, hydrolysed gelatin, urea, sodium chloride, sorbitol, monosodium glutamate, sodium phosphate, sodium bicarbonate, potassium phosphate, potassium chloride, medium 199 with Hanks’ Salts, MEM, neomycin, phenol red, HCl, NaOH.
Saccharose, hydrolyseret gelatine, urinstof, natriumchlorid, sorbitol, mononatriumglutamat, natriumphosphat, natriumbicarbonat, kaliumphosphat, kaliumchlorid, medium 199 med Hanks salte, MEM, neomycin, phenolrødt, saltsyre, natriumhydroxid.
Sucrose, hydrolysed gelatin, urea, sodium chloride, sorbitol, monosodium glutamate, sodium phosphate, sodium bicarbonate, potassium phosphate, potassium chloride, medium 199 with Hanks’ Salts, MEM, neomycin, phenol red, hydrochloric acid and sodium hydroxide.
Saccharose, mannitol, eddikesyre og natriumhydroxid.
Sucrose, mannitol, glacial acetic acid, and sodium hydroxide.
Saccharose, natriumchlorid, natriumphosphat (monobasisk monohydrat), natriumphosphat (dibasisk heptahydrat) og vand til injektionsvæsker.
Sucrose, sodium chloride, sodium phosphate monobasic monohydrate, sodium phosphate dibasic heptahydrate and water for injections.
Saccharose, natriumchlorid, natriumphosphat monobasisk monohydrat, natriumphosphat dibasisk heptahydrat og vand til injektionsvæsker.
Sucrose, sodium chloride, sodium phosphate monobasic monohydrate, sodium phosphate dibasic heptahydrate and water for injections.
Saccharose, saccharose, glycin, natriumchlorid, kalciumchlorid, polysorbat 80.
Sucrose, histidine, glycine, sodium chloride, calcium chloride, polysorbate 80.
Saccharosekugler (saccharose og majsstivelse), hypromellose, ethylcellulose N7, macrogol 1500, povidon K25.
ugar spheres (sucrose and maize starch), hypromellose, ethylcellulose N7, macrogol 1500, povidone K25.
Safinamid absorption er hurtig efter enkelt eller multipel oral dosering og nåede tmax i tidsintervallet 1,8- 2,8 timer efter dosering under faste.
Safinamide absorption is rapid after single and multiple oral dosing, reaching Tmax in the time range 1.8-2.8 h after dosing under fasting conditions.
Safinamid anvendt som et supplement til levodopa kan forstærke bivirkningerne ved levodopa, og præ-eksisterende dyskinesi kan forværres, hvilket kan kræve nedsættelse af levodopa.
Safinamide used as an adjunct to levodopa may potentiate the side effects of levodopa, and pre- existing dyskinesia may be exacerbated, requiring a decrease of levodopa.
Safinamid er forbundet med tilstandsafhængig hæmning af spændingsstyrede natriumkanaler (Na+) og modulation af stimuleret frigivelse af glutamat.
Safinamide is associated with state-dependent inhibition of voltage-gated sodium (Na+) channels, and modulation of stimulated release of glutamate.
Safinamid forventes at blive udskilt i mælken, idet der er observeret bivirkninger hos rotteunger, som blev eksponeret via mælk (se pkt.
Safinamide is expected to be excreted in milk as adverse reactions have been observed in rat pups exposed via milk (see section 5.3).
Safinamid hæmmer BCRP i tyndtarmen midlertidigt (se pkt.
Safinamide transiently inhibits BCRP in the small intestine (see section 4.5). .
Safinamids metabolisme afhænger ikke af cytochrom P450 (CYP)- baserede enzymer.
Safinamide’s metabolism is not dependent on Cytochrome P450 (CYP) based enzymes.
Sage house, 319 Pinner road, Harrow, HA1 4HF Storbritannien
Sage house, 319 Pinner road, Harrow, HA1 4HF United Kingdom
Sage House, 319 Pinner Road, North Harrow HA1 4 HF, Middlesex Storbritannien
Sage House, 319 Pinner Road, North Harrow, HA1 4 HF, Middlesex United Kingdom
Sage House, 319 Pinner Road, North Harrow, HA1 4 HF, Middlesex Storbritannien
Sage House, 319 Pinner Road, North Harrow, HA1 4 HF, Middlesex United Kingdom
Sagerne var typiske for sekundært MDS/cancerbehandlingsrelateret AML.
The cases were typical of secondary MDS/cancer therapy-related AML.
Sakkarose (37,8 mg)
Sucrose (37.8 mg)
Sakl helst anvendes straks efter opblanding Læs indlægssedlen før brug
Administration should preferably take place immediately after reconstitution Read package leaflet before use
Salamanca 37080 Spanien
Salamanca 37080 Spain
salg til
horised
Salgs-
Package
Salicylater (f.eks. aspirin)
Salicylates (e.g. aspirin)
Salicylater (f.eks. aspirin)
Salicylates (e.g. aspirin).
Salicylater (f.eks. aspirin).
Salicylates (e.g. aspirin).
Salicylater (smertestillende og febernedsættende)
Salicylates (used to relieve pain and lower fever)
Salicylater må ikke anvendes til børn og unge i 4 uger efter vaccinationen, med mindre det er medicinsk indiceret, da tilfælde af Reyes syndrom er blevet rapporteret efter brug af salicylater ved infektioner med vildtype-influenza.
Do not use salicylates in children and adolescents for 4 weeks after vaccination unless medically indicated as Reye’s syndrome has been reported following the use of salicylates during wild-type influenza infection.
Salicylater må ikke anvendes til børn og unge under 18 år i 4 uger efter vaccinationen, med mindre det er medicinsk indiceret, da tilfælde af Reyes syndrom er blevet rapporteret efter brug af salicylater ved infektioner med vildtype-influenza.
Do not use salicylates in children and adolescents younger than 18 years of age for 4 weeks after vaccination unless medically indicated as Reye’s syndrome has been reported following the use of salicylates during wild-type influenza infection.
Salicylsyre bliver primært konjugeret i leveren og danner salicylurinsyre, et phenolisk glukuronid, et acylglukuronid og et antal mindre metabolitter.
Salicylic acid is primarily conjugated in the liver to form salicyluric acid, a phenolic glucuronide, an acyl glucuronide, and a number of minor metabolites.
Salinsk buffer
Saline buffer
Salmeterol
Avanafil
salmeterol (bruges til at behandle astma)
almeterol (used to treat asthma)
Salmeterol (mod astma eller kronisk obstruktiv lungesygdom (KOL))
Salmeterol (for asthma or chronic obstructive pulmonary disease (COPD)
Salmeterol (mod astma eller kronisk obstruktiv lungesygdom (KOL))
Salmeterol (for asthma or chronic obstructive pulmonary disease (COPD))
Salmeterol 50 to gange dagligt
Salmeterol 50 twice a day
Salmeterol bør ikke administreres sammen med idelalisib.
Concurrent administration of salmeterol and idelalisib is not recommended.
Salmeterol er en selektiv langtidsvirkende (12 timer) β2-agonist med en lang sidekæde, som binder til receptorens exo-site.
Salmeterol is a selective long-acting (12 hour) β2 adrenoceptor agonist with a long side chain which binds to the exo-site of the receptor.
Salmeterol giver en længere varende bronkodilatation (varighed mindst 12 timer) end anbefalede doser af konventionelle hurtigtvirkende β2-agonister.
Salmeterol produces a longer duration of bronchodilation, lasting for at least 12 hours, than recommended doses of conventional short-acting β2 agonists.
Salmeterol Multi-center Asthma Research Trial (SMART)
The Salmeterol Multi-center Asthma Research Trial (SMART)
Salmeterol Ritonavir hæmmer CYP3A4 og som følge heraf forventes en udtalt stigning i plasmakoncentrationerne af salmeterol.
Salmeterol Ritonavir inhibits CYP3A4 and as a result a pronounced increase in the plasma concentrations of salmeterol is expected.
Salmeterol tilhører en gruppe lægemidler, der kaldes langtidsvirkende bronkodilatatorer.
Salmeterol is a long-acting bronchodilator.
salmeterol/fluticasonpropionat Til inhalation
salmeterol/fluticasone propionate Inhalation use
salmeterol/fluticasonpropionat Til inhalation.
salmeterol/fluticasone propionate Inhalation use
Salmeterol:
Avanafil:
Salmeterol:
Salmeterol
Salmiakspiritus (E527)
Strong Ammonia Solution (E527)
Salt- og vandophobning i kroppen, der medfører hævelse og forhøjet blodtryk (påvist ved lægeundersøgelse) samt lavt kaliumniveau i blodet
Salt and water retention causing swelling and raised blood pressure (shown on medical examination) and low potassium level in the blood
Saltmangel som følge af langvarig alvorlig diarré og opkastning eller brug af vanddrivende medicin (diuretika)
If you know that you may have salt depletion as a result of prolonged severe diarrhoea and vomiting (being sick) or usage of diuretics (water tablets)
Saltsyre
Sodium hydroxide
Saltsyre (0,04 M)
Hydrochloric acid (0.04 M)
Saltsyre (E507) (til justering af pH) Vand til injektion
Hydrochloric acid (E507) (for pH adjustment) Water for injections
Saltsyre (E507) (til pH-justering) Vand til injektionsvæsker
Hydrochloric acid (E507) (for pH-adjustment) Water for injections
Saltsyre (E507) Natriumhydroxid (E524) Majsstivelse Lactosemonohydrat Talcum (E553b)
Lactose monohydrate Talc (E553b)
Saltsyre (E507) til justering af pH Vand til injektion
Hydrochloric acid (E507) (for pH adjustment) Water for injections
Saltsyre (E507) Vand til injektion
Hydrochloric acid (E507) Water for injections
Saltsyre (til justering af pH-værdien) Natriumhydroxid (til justering af pH-værdien)
Hydrochloric acid (for pH-adjustment) Sodium hydroxide (for pH-adjustment)
Saltsyre (til pH-justering)
Zinc acetate
Saltsyre (til pH-justering) Natriumhydroxyd (til pH-justering)
Hydrochloric acid (for pH-adjustment) Sodium hydroxide (for pH-adjustment)
Saltsyre (til pH-justering) Polysorbate 20
Hydrochloric acid (for pH adjustment) Polysorbate 20
Saltsyre (til pH-justering) Vand til injektionsvæsker
Hydrochloric acid (for pH adjustment) Water for injections
Saltsyre (til pH-justering) Vand til injektionsvæsker.
Hydrochloric acid (for pH adjustment) Water for injections
Saltsyre eller natriumhydroxid (til pH-justering) Vand til injektionsvæsker.
Hydrochloric acid or sodium hydroxide (for pH adjustment) Water for injection.
Saltsyre og natriumhydroxid (for justering af pH).
Hydrochloric acid and sodium hydroxide (for pH adjustment).
Saltsyre og natriumhydroxid kan være tilsat for at justere pH til 7,0-7,8.
Hydrochloric acid and sodium hydroxide may be used to adjust pH to 7.0 – 7.8.
Saltsyre og natriumhydroxid kan være tilsat for at justere pH til 7,0-7,8.
Hydrochloric acid and sodium hydroxide may be used to adjust pH to 7.0-7.8.
Saltsyre og natriumhydroxid kan være tilsat for at justere pH til 7,0-7,8.
Hydrochloric acid and sodium hydroxide maybe used to adjust pH to 7.0 – 7.8.
Saltsyre og/eller natriumhydroxid, (pH justering)
Hydrochloric acid and/or sodium hydroxide (pH adjustment)
Saltsyre som pH-justering Vand til injektionsvæsker
Hydrochloric acid as pH adjuster Water for injections
Saltsyre, 0,1 N.
Hydrochloric acid 0.1 N.
Saltsyre, fortyndet
Hydrochloric acid, dilute
Saltsyre, fortyndet (til justering af pH) Pentetatsyre
Hydrochloric acid, diluted (for pH adjustment) Pentetic acid
Saltsyre, natriumhydroxyd (til pH-justering).
Hydrochloric acid, sodium hydroxide (for pH adjustment).
Saltsyre/natriumhydroxid (til justering af pH ) Renset vand.
Hydrochloric acid/sodium hydroxide (to adjust pH) Purified water.
Saltsyre/Natriumhydroxid (til justering af pH) Renset vand.
Hydrochloric acid/sodium hydroxide (to adjust pH) Purified water
Saltsyre5
Hydrochloric acid5
Saltsyreopløsning og/eller natriumhydroxidopløsning ( til pH-justering).
Hydrochloric acid solution and/or sodium hydroxide solution (for pH adjustment).
Salve
Ointment
Salve.
Ointment.
Samarium (153Sm) lexidronam pentanatrium: 1,3 GBq/ml på referencedato. (svarende til 20 - 80 µg/ml samarium)
Samarium (153Sm) lexidronam pentasodium : 1.3 GBq/ml at reference date. (Corresponding to 20 to 80 µg/ml of samarium)
Samenvatting van het veiligheidsprofiel
Summary of the safety profile
Samfundserhvervet pneumoni
Community acquired pneumonia
Samfundserhvervet pneumoni
Community Acquired Pneumonia (CAP)
Samfundserhvervet pneumoni (CAP; community acquired pneumonia)
Community-acquired pneumonia (CAP)
Saml alle de materialer, du skal bruge til injektionen.
Gather all materials needed for your injection.
Saml alle tingene:
Gather all supplies:
Saml alt det, du skal bruge til infusionen.
Collect all items for your infusion.
Saml alt du har brug for og læg alt frem:
Get together everything you need and lay them out:
Saml alt du har brug for og læg det frem:
Gather everything you need and lay it out:
Saml alt du har brug for og læg det frem:
Get together everything you need and lay them out::
Saml de ting du skal bruge til injektionen og læg dem på den valgte arbejdsflade:
Gather the items that you will need for your injection, and place them on the chosen surface:
Saml det nødvendige udstyr, før De begynder: et hætteglas med Viraferon injektionsvæske, opløsning,
Collect necessary items before you begin: a vial of Viraferon solution for injection;
Saml det nødvendige udstyr, før De begynder: et hætteglas med Viraferon pulver til injektionsvæske, opløsning, en ampul med solvens til Viraferon (vand til injektionsvæsker 1 ml),
Collect necessary items before you begin: a vial of Viraferon powder for injection; an ampoule of solvent for Viraferon (water for injections 1 ml);
Saml det nødvendige udstyr, før du begynder: et hætteglas med IntronA injektionsvæske, opløsning,
Collect necessary items before you begin: a vial of IntronA solution for injection;
Saml det nødvendige udstyr, før du begynder: et hætteglas med IntronA injektionsvæske, opløsning, en 1 ml sprøjte med påsat kanyle og kanylehætte (BD SafetyGlide injektionssprøjte), en renseserviet.
Collect necessary items before you begin: a vial of IntronA solution for injection; a 1 mL syringe with an attached needle and a needle protection device (BD SafetyGlide syringe); a cleansing swab.
Saml det nødvendige udstyr, før du begynder: et hætteglas med PegIntron pulver til injektionsvæske en ampul med solvens, vand til injektionsvæsker til at fremstille PegIntron-opløsningen,
Collect the necessary items before you begin: a vial of PegIntron powder for injection; an ampoule of water for injections solvent to prepare PegIntron injection;
Saml det nødvendige udstyr, før du begynder: et hætteglas med ViraferonPeg pulver til injektionsvæske en ampul med solvens, vand til injektionsvæsker til at fremstille ViraferonPeg-opløsningen,
Collect the necessary items before you begin: a vial of ViraferonPeg powder for injection; an ampoule of water for injections solvent to prepare ViraferonPeg injection;
Saml tingene sammen.
Collect supplies.
Samlebegrebet ”brændende fornemmelse” betyder brændende fornemmelse, brændende hudfornemmelse og irritation på administrationsstedet, som alle specifikt referererer til brænden på administrationsstedet.
The bundled term burning sensation consists of the preferred terms burning sensation, skin burning sensation, and application site irritation, all of which referred specifically to burning at the application site.
Samlede analyser af kliniske studier
Pooled analyses of clinical trials
Samlede analyseresultater af bivirkningsdata fra placebo-kontrollerede studier med patienter med Parkinsons sygdom tyder på, at samtidig administration af safinamid sammen med en bred kategori af almindeligt anvendte lægemidler i denne patientgruppe (antihypertensiva, beta-blokkere, kolesterolsænkende, ikke-steroide anti-inflammatoriske, protonpumpe-hæmmere, antidepressiva, etc.) ikke var forbundet med en øget risiko for bivirkninger.
Pooled analyses of adverse event data from placebo controlled studies in Parkinson’s disease patients indicate that the concomitant administration of safinamide together with a broad category of commonly used medicinal products in this patient population (antihypertensive, beta-blockers cholesterol lowering, non-steroidal anti-inflammatory medicinal products, proton pump inhibitors, antidepressants, etc.) was not associated with an increased risk for adverse events.
Samlede behandlingsresultater efter 48 og 96 uger vises i tabel 3.
Pooled treatment outcomes at 48 and 96 weeks are shown in Table 3.
Samlede behandlingsresultater efter 48 og 96 uger vises i tabel 4.
Pooled treatment outcomes at 48 and 96 weeks are shown in Table 4.
Samlede bivirkninger ved Trevaclyn
Tabulated list of adverse reactions
Samlede data
Pooled Data
Samlede data fra begge studier.
Summary data from both studies.
Samlede data fra det centrale RCC-studie (VEG105192, n = 290), det forlængede studie (VEG107769, n = 71), det understøttende fase II-studie (VEG102616, n = 225) og det randomiserede, ublindede, parallelgruppe fase III non-inferioritets studie (VEG108844, n = 557) blev vurderet i den overordnede evaluering af sikkerheden ved og tolerancen over for pazopanib (i alt n = 1149) hos forsøgspersoner med RCC (se pkt.
Pooled data from the pivotal RCC trial (VEG105192, n=290), extension study (VEG107769, n=71), the supportive Phase II trial (VEG102616, n=225) and the randomised, open-label, parallel group Phase III non- inferiority study (VEG108844, n=557) was evaluated in the overall evaluation of safety and tolerability of pazopanib (total n=1149) in subjects with RCC (see section 5.1).
Samlede data fra POWER 1 og POWER 2
POWER 1 and POWER 2 pooled data
Samlede effektanalyser over 6 måneders behandling viste, at frekvensen af KOL-eksacerbationer var statistisk signifikant lavere end for placebo.
Pooled efficacy analysis over 6 months’ treatment demonstrated that the rate of COPD exacerbations was statistically significantly lower than the placebo rate.